Menopause changes the rules on weight loss. Declining oestrogen, slowing metabolism, shifting fat distribution, and sleep disruption can make even the most disciplined eating plan feel futile. Increasingly, South African women in perimenopause and menopause are asking their doctors about Ozempic. Here is what you need to know before considering it.
Between the ages of 45 and 55, most South African women go through menopause — a transition that fundamentally changes how the body stores and burns fat. Understanding these changes is critical before considering any medication.
These factors mean that the diet that worked at 35 often stops working at 50. That is not a failure of willpower — it is biology. For deeper reading on these mechanisms, see our menopause weight gain guide.
Ozempic contains semaglutide, a GLP-1 receptor agonist. It mimics a natural gut hormone that:
Two of the biggest drivers of menopausal weight gain are insulin resistance and increased appetite. Semaglutide directly targets both. Unlike restrictive diets that fight against your hormones, semaglutide works with the body's signalling system to reduce caloric intake naturally.
For a full breakdown of how semaglutide works and clinical trial results, see our semaglutide weight loss guide.
Most large semaglutide trials (STEP 1-5) included women across age groups, but did not publish menopause-specific subgroup data. Here is what we do know:
| Outcome | Women under 50 | Women 50+ |
|---|---|---|
| Average weight loss (68 weeks, 2.4 mg) | 15-17% | 10-13% |
| Visceral fat reduction | Significant | Significant (similar benefit) |
| HbA1c improvement | Moderate | Often greater (higher baseline insulin resistance) |
| Muscle mass loss risk | Moderate | Higher — requires protein + resistance training |
| Bone density concern | Low | Moderate — DEXA monitoring recommended |
| Nausea/GI side effects | Common (40-45%) | Similar frequency, may take longer to resolve |
| Dropout rate | ~7% | ~10% (often due to GI side effects) |
The lower weight loss percentage in women over 50 is not surprising — it reflects metabolic changes, not treatment failure. A 10-13% reduction in body weight is still clinically significant and is enough to improve cardiovascular risk markers, reduce visceral fat, lower blood pressure, and improve sleep apnoea.
This is one of the most common questions South African women ask. The short answer: yes.
This information is general guidance. Every woman's hormonal profile, medical history, and risk factors are different. Never start or stop HRT or Ozempic without consulting your prescribing doctor. In South Africa, an endocrinologist, gynaecologist, or GP with hormone therapy experience can guide this decision.
Semaglutide is generally well-tolerated, but menopausal women face specific risks that younger users may not:
Menopause already accelerates bone loss due to declining oestrogen. Rapid weight loss from any cause further reduces bone density. Women on semaglutide should:
Up to 40% of weight lost on GLP-1 medications can be lean mass (muscle) rather than fat. For menopausal women already losing muscle, this is a serious concern. Mitigation requires:
For more detail, read our guide on preventing muscle loss on GLP-1 medications.
Rapid weight loss increases gallstone risk, and women over 40 are already in a higher risk group. If you experience severe upper-right abdominal pain after starting semaglutide, see your doctor urgently.
Semaglutide carries a black box warning for medullary thyroid carcinoma based on rodent studies. While human risk appears low, menopausal women should have thyroid function tested (TSH, free T4) before starting and periodically during treatment. This is especially important because thyroid disorders are more common in women over 45.
Menopause does not change the price, but it may change how you approach the cost decision — many women in this age group are on single incomes, supporting adult children, or approaching retirement.
| Option | Monthly Cost (ZAR) | Notes |
|---|---|---|
| Ozempic 0.5 mg (starter dose) | R3,500-R4,000 | Available at Dis-Chem, Clicks, Medirite |
| Ozempic 1 mg (maintenance) | R4,500-R5,500 | Most common dose for weight loss |
| Wegovy 2.4 mg | R5,500-R7,000 | Dedicated weight loss dose — supply intermittent in SA |
| Compounded semaglutide | R800-R2,500 | Cheaper but verify pharmacy credentials carefully |
| Rybelsus (oral) | R2,800-R3,800 | Oral tablet, no injections — lower efficacy for weight loss |
| Doctor consultations (ongoing) | R500-R1,200/visit | GP cheaper than endocrinologist; quarterly visits typical |
| Blood work (HbA1c, lipids, thyroid) | R400-R800/panel | Every 3-6 months recommended |
Total realistic monthly budget: R4,500-R7,000 including medication, doctor visits, and supplements (calcium, vitamin D, protein). This is a significant investment. If budget is a concern, explore our Ozempic alternatives guide — some options like Contrave are available from approximately R1,200 per month.
Most SA medical aids (Discovery, Momentum, Bonitas) do not cover Ozempic for weight loss. If you have type 2 diabetes, coverage is more likely under chronic medication benefits. Ask your doctor about coding the prescription under ICD-10 E11.9 (type 2 diabetes) or E66.0 (obesity) and submit a motivation letter to your scheme. Some women have success with Section 21 applications.
Semaglutide is not a standalone solution. For the best results during menopause, combine it with targeted lifestyle changes:
For a structured exercise plan, see our exercise plan for women over 40.
Breakfast (7:00): 2 scrambled eggs on 1 slice rye toast with half an avocado. Rooibos tea. (~22 g protein)
Snack (10:30): Small handful of biltong (30 g) + 5 almonds. (~12 g protein)
Lunch (13:00): Tinned pilchards on salad with chickpeas, cucumber, tomato, olive oil dressing. (~28 g protein)
Afternoon (15:30): Plain Greek yoghurt with 1 tbsp ground flaxseed and a few berries. (~15 g protein)
Dinner (18:30): Grilled chicken breast (150 g) with roasted butternut, steamed broccoli, and a drizzle of olive oil. (~35 g protein)
Daily total: ~112 g protein, ~1,400 calories — appropriate for a moderately active 70 kg woman on semaglutide during menopause.
Note: Semaglutide significantly reduces appetite, so eating enough (especially protein) can actually be the challenge. Do not skip meals. Undereating accelerates muscle loss.
Semaglutide is not suitable for everyone. It may not be the right option if:
For non-medication approaches, our menopause weight loss guide covers evidence-based diet and exercise strategies, and intermittent fasting for women offers a structured approach some menopausal women find effective.
| Option | Monthly Cost | How It Helps | Menopause Suitability |
|---|---|---|---|
| Mounjaro (tirzepatide) | R5,000-R8,000 | Dual GIP/GLP-1 — potentially more effective | Good — same considerations apply |
| Saxenda (liraglutide) | R3,000-R4,500 | Daily GLP-1 injection | Good — lower efficacy than semaglutide |
| Contrave | R1,200-R1,800 | Reduces cravings, especially emotional eating | Good for menopause-related emotional eating |
| HRT alone | R300-R800 | Addresses root hormonal cause | Excellent — first-line for hormonal symptoms |
| Intermittent fasting | Free | Improves insulin sensitivity | Good with modifications for hormonal health |
| Anti-inflammatory diet | R2,000-R4,000 (groceries) | Reduces inflammation, supports hormonal balance | Excellent — complements any other approach |
Not sure which medication is right for you? Our comprehensive comparison covers all major options available in SA — with pricing, efficacy data, and side-by-side tables.
View Full ComparisonYes. Ozempic (semaglutide) can be prescribed to menopausal women who meet the criteria — typically a BMI of 30+ or 27+ with a weight-related condition like type 2 diabetes or hypertension. Menopause itself is not a contraindication. However, your doctor will consider factors like bone density, muscle mass, and overall hormonal health before prescribing.
The GLP-1 mechanism works the same regardless of menopausal status — semaglutide slows gastric emptying, reduces appetite, and improves insulin sensitivity. However, menopausal women may lose weight more slowly due to lower oestrogen, reduced metabolic rate, and age-related muscle loss. Clinical data shows women over 50 typically achieve 10-13% weight loss on semaglutide versus 15-17% in younger populations.
Yes, Ozempic and hormone replacement therapy (HRT) can generally be used together. There are no known drug interactions between semaglutide and oestrogen or progesterone. Some doctors believe the combination may actually produce better outcomes — HRT addresses the hormonal root cause of metabolic slowdown while semaglutide helps with appetite and blood sugar. Always discuss with your prescribing doctor.
Semaglutide reduces overall body fat, and clinical data shows it does reduce visceral (belly) fat — the type that increases during menopause due to oestrogen decline. However, you cannot target belly fat specifically. The combination of semaglutide with resistance training and adequate protein intake (1.2-1.6 g per kg body weight) gives the best results for body composition during menopause.
Rapid weight loss from any cause — including semaglutide — can accelerate bone density loss, which is already a concern during menopause. Clinical trials have not shown semaglutide directly damages bone, but losing more than 1 kg per week increases the risk. Your doctor may recommend a DEXA scan before starting, calcium and vitamin D supplementation, and regular weight-bearing exercise to protect bone health.
There is no fixed duration. Most doctors recommend staying on semaglutide for at least 12-18 months to achieve target weight loss and establish sustainable habits. Stopping often leads to weight regain (studies show 60-70% of weight is regained within 12 months of stopping). Some women choose to remain on a maintenance dose long-term. This is a decision to make with your doctor based on your goals, side effects, and budget.
Menopause changes the weight loss equation, but it does not make it impossible. Ozempic (semaglutide) can be a powerful tool for menopausal women — it directly targets the insulin resistance and increased appetite that drive menopausal weight gain.
However, it works best as part of a comprehensive approach:
The goal is not to look like you did at 30. It is to be healthy, strong, and metabolically fit for the decades ahead.